---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-06-18T02:59:23.764665'
end_time: '2026-06-18T03:12:37.999029'
duration_seconds: 794.23
template_file: /Users/marcin/Documents/VIMSS/ontology/KG-Hub/KG-Microbe/TraitMech/templates/trait_causal_graph_research.md
template_variables:
  trait_label: CRISPR-Cas system
  trait_identifier: traitmech:000094
  trait_category: GENOMICS
  trait_category_slug: genomics
  trait_slug: crispr_cas_system
  term_kind: CLASS
  mapping_status: REVIEWED
  definition: A genomics trait describing possession of a CRISPR-Cas adaptive immune
    system that records fragments of invading nucleic acids in CRISPR arrays and uses
    Cas proteins to recognize and cleave matching sequences.
  parent_traits: METPO:1000188
  synonyms: CRISPR array
  evidence_summary: 'DOI:10.1038/s41579-019-0299-x:  (Makarova et al. present an evolutionary
    classification of CRISPR-Cas systems into two classes, six types, and many subtypes.)
    | DOI:10.1016/j.molcel.2014.03.011:  (Barrangou & Marraffini review CRISPR-Cas
    as prokaryotic adaptive immunity against invading genetic elements.)'
  causal_graph_summary: 'crispr_adaptive_immunity: 3 nodes, 2 edges'
provider_config:
  timeout: null
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 48
---

## Question

# Microbial Trait Causal Graph Research Template

## Target Trait
- **Trait label:** CRISPR-Cas system
- **METPO identifier:** traitmech:000094
- **Trait category:** GENOMICS
- **Term kind:** CLASS
- **Mapping status:** REVIEWED
- **Definition:** A genomics trait describing possession of a CRISPR-Cas adaptive immune system that records fragments of invading nucleic acids in CRISPR arrays and uses Cas proteins to recognize and cleave matching sequences.
- **Parent traits:** METPO:1000188
- **Synonyms:** CRISPR array
- **Existing evidence:** DOI:10.1038/s41579-019-0299-x:  (Makarova et al. present an evolutionary classification of CRISPR-Cas systems into two classes, six types, and many subtypes.) | DOI:10.1016/j.molcel.2014.03.011:  (Barrangou & Marraffini review CRISPR-Cas as prokaryotic adaptive immunity against invading genetic elements.)
- **Existing causal graph summary:** crispr_adaptive_immunity: 3 nodes, 2 edges

## Research Objective

Research the microbial trait **CRISPR-Cas system** as a candidate TraitMech causal graph.
Focus on source-backed mechanistic entities and causal edges that can be curated into
`data/traits/genomics/crispr_cas_system.yaml`.

## Required Findings

### 1. Trait Scope
- Clarify what phenotype, physiological capacity, environmental preference, or assay-observed
  property the trait represents.
- Identify boundary cases and distinguish the trait from nearby traits.

### 2. Causal Graph Entities
- Pathways and metabolic modules.
- Environmental factors and experimental factors.
- Genes, proteins, enzymes, transporters, and complexes.
- Chemicals, electron donors, electron acceptors, nutrients, metabolites, and inhibitors.
- Organelles, cellular localizations, molecular functions, and biological processes.

### 3. Evidence-Backed Edges
- Propose causal edges as subject-predicate-object triples.
- For every proposed edge, provide a reference, a short supporting quote/snippet, and notes
  explaining how the source supports the edge.
- Prefer DOI references. Use PMID only when a DOI is not available.
- Mark weak, taxon-specific, assay-specific, or inferred claims as uncertain.

### 4. Ontology Grounding
- Suggest CURIEs where available: METPO, GO, CHEBI, ENVO, NCBITaxon, EC, UniProt, Rhea,
  KEGG, MetaCyc, or other stable identifiers.
- Do not invent identifiers. Label-only candidate nodes are acceptable when grounding is unclear.

## Output Format

Return a curation-focused report with:
- A short scope summary.
- Candidate nodes grouped by type.
- Candidate causal edges in a table with reference, snippet, and notes.
- DOI-first bibliography.
- Warnings for claims that should not yet be curated into TraitMech.


## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Microbial Trait Causal Graph Research Template

## Target Trait
- **Trait label:** CRISPR-Cas system
- **METPO identifier:** traitmech:000094
- **Trait category:** GENOMICS
- **Term kind:** CLASS
- **Mapping status:** REVIEWED
- **Definition:** A genomics trait describing possession of a CRISPR-Cas adaptive immune system that records fragments of invading nucleic acids in CRISPR arrays and uses Cas proteins to recognize and cleave matching sequences.
- **Parent traits:** METPO:1000188
- **Synonyms:** CRISPR array
- **Existing evidence:** DOI:10.1038/s41579-019-0299-x:  (Makarova et al. present an evolutionary classification of CRISPR-Cas systems into two classes, six types, and many subtypes.) | DOI:10.1016/j.molcel.2014.03.011:  (Barrangou & Marraffini review CRISPR-Cas as prokaryotic adaptive immunity against invading genetic elements.)
- **Existing causal graph summary:** crispr_adaptive_immunity: 3 nodes, 2 edges

## Research Objective

Research the microbial trait **CRISPR-Cas system** as a candidate TraitMech causal graph.
Focus on source-backed mechanistic entities and causal edges that can be curated into
`data/traits/genomics/crispr_cas_system.yaml`.

## Required Findings

### 1. Trait Scope
- Clarify what phenotype, physiological capacity, environmental preference, or assay-observed
  property the trait represents.
- Identify boundary cases and distinguish the trait from nearby traits.

### 2. Causal Graph Entities
- Pathways and metabolic modules.
- Environmental factors and experimental factors.
- Genes, proteins, enzymes, transporters, and complexes.
- Chemicals, electron donors, electron acceptors, nutrients, metabolites, and inhibitors.
- Organelles, cellular localizations, molecular functions, and biological processes.

### 3. Evidence-Backed Edges
- Propose causal edges as subject-predicate-object triples.
- For every proposed edge, provide a reference, a short supporting quote/snippet, and notes
  explaining how the source supports the edge.
- Prefer DOI references. Use PMID only when a DOI is not available.
- Mark weak, taxon-specific, assay-specific, or inferred claims as uncertain.

### 4. Ontology Grounding
- Suggest CURIEs where available: METPO, GO, CHEBI, ENVO, NCBITaxon, EC, UniProt, Rhea,
  KEGG, MetaCyc, or other stable identifiers.
- Do not invent identifiers. Label-only candidate nodes are acceptable when grounding is unclear.

## Output Format

Return a curation-focused report with:
- A short scope summary.
- Candidate nodes grouped by type.
- Candidate causal edges in a table with reference, snippet, and notes.
- DOI-first bibliography.
- Warnings for claims that should not yet be curated into TraitMech.


## Microbial Trait Causal Graph Curation Report: CRISPR–Cas system (traitmech:000094)

### Scope summary (TraitMech curation)
The **CRISPR–Cas system** trait refers to the **genomic capacity for prokaryotic adaptive immunity** encoded at a CRISPR locus, typically comprising **(i) a CRISPR repeat–spacer array** (leader + repeats + spacers) and **(ii) associated cas genes** whose products execute spacer acquisition, crRNA biogenesis, and interference against invading nucleic acids such as phages and plasmids. Mechanistically, recent reviews emphasize three canonical functional stages: **adaptation (spacer acquisition), expression/processing (crRNA biogenesis), and interference (crRNA-guided target neutralization)** (oh2024harnessingcrisprcasadaptation pages 1-2, cheng2024insightintothe pages 1-2).

**Boundary cases relevant for curation**:
1. **CRISPR arrays without cas genes (“orphan CRISPRs”)**: These are common enough to warrant a separate node/trait state; e.g., in *Salmonella enterica*, 17.66% of analyzed genomes contained orphan CRISPRs while 82.33% contained complete systems (fallah2024comprehensiveanalysisof pages 1-2).
2. **Degenerate/decaying arrays**: terminal “degenerated repeats” and degraded repeats near self-targeting spacers indicate locus decay; these should not be conflated with intact functional systems (sabri2024comprehensiveanalysisof pages 5-7).
3. **Mobile genetic element (MGE)-encoded CRISPR variants**: plasmids/phages/transposons may encode partial CRISPR modules (often lacking adaptation modules) for **noncanonical functions** such as transcriptional repression or RNA-guided transposition (koonin2024crisprinmobile pages 4-6, benz2024typeiva3crisprcas pages 1-3, koonin2024crisprinmobile pages 1-2).
4. **Inhibited-but-present systems**: anti-CRISPR proteins and RNA anti-CRISPRs can inactivate CRISPR-Cas function without eliminating the locus (camarawilpert2023bacteriophagessuppresscrispr–cas pages 1-2, sun2023anticrispracriic5is pages 1-2).

### 1) Key concepts and definitions (current understanding)

#### Modular architecture
Recent syntheses define CRISPR loci as **arrays + cas genes**, with spacer sequences derived from mobile elements and stored as heritable “memories” (cheng2024insightintothe pages 1-2, oh2024harnessingcrisprcasadaptation pages 1-2). The Cas machinery is organized into two major functional modules:
- **Adaptation (spacer acquisition)**: often centered on the conserved **Cas1–Cas2 integrase** that inserts spacers at the leader-proximal end of the array (oh2024harnessingcrisprcasadaptation pages 1-2).
- **Effector module (expression/processing + interference)**: CRISPR arrays are transcribed and processed to **crRNAs**, which assemble with Cas effectors to recognize and neutralize targets (cheng2024insightintothe pages 1-2, oh2024harnessingcrisprcasadaptation pages 1-2).

#### Classification (Class 1 vs Class 2; types I–VI)
A current, commonly used organization is:
- **Class 1**: multi-subunit effector complexes; includes types **I, III, IV**.
- **Class 2**: single, large effector proteins; includes types **II (Cas9), V (Cas12), VI (Cas13)** (oh2024harnessingcrisprcasadaptation pages 1-2).

Type-to-target modality summary:
- **DNA-targeting**: types **I/II/IV/V** (oh2024harnessingcrisprcasadaptation pages 1-2).
- **RNA-targeting**: types **III/VI** (oh2024harnessingcrisprcasadaptation pages 1-2).
A useful negative constraint for boundary conditions: **Cas9 does not directly interact with RNA** (sabri2024comprehensiveanalysisof pages 5-7).

### 2) Recent developments and latest research (prioritized 2023–2024)

#### RNA-based anti-CRISPRs (repeat mimicry)
A major 2023 advance was the discovery of **RNA-based anti-CRISPRs (Racrs)** that mimic CRISPR repeats and inhibit immunity by binding CRISPR proteins. A prophage-encoded Racr inhibited a type I-F system by interacting with **Cas6f and Cas7f** to form an aberrant complex, and functional testing supported broad inhibitory capacity across CRISPR types (camarawilpert2023bacteriophagessuppresscrispr–cas pages 1-2). This introduces a new mechanistic inhibitor class that is directly relevant to causal graphs describing when a “present” system is functionally off.

#### Anti-CRISPR mechanism resolution (protein Acrs)
A 2023 structural study showed **AcrIIC5** inhibits type II-C Cas9 by acting as a **dsDNA mimic** that occludes the **PAM-binding site**, preventing PAM recognition (sun2023anticrispracriic5is pages 1-2). A 2024 review compiles residue-level mechanisms for multiple Acr families across types I–III and class 2 effectors, including **Cas3 inhibition** (AcrIF3), **Cascade/Cas7 blockade** (AcrIF1), and **type III cOA pathway disruption** via **AcrIII-1 ring nucleases that degrade cA4** (allemailem2024currentupdatesof pages 12-14, allemailem2024currentupdatesof pages 14-16).

#### CRISPR in mobile genetic elements and “noncanonical” functions
A 2024 synthesis emphasizes that MGEs recruit CRISPR components for counter-defense, inter-element competition, and transposition: phages can encode functional CRISPR systems targeting host defenses; plasmids frequently encode type IV or subtype V-M CRISPR implicated in inter-plasmid competition; and Tn7-like/Mu-like transposons encode CAST systems that use guide RNAs for **RNA-guided site-specific transposition** (koonin2024crisprinmobile pages 1-2, koonin2024crisprinmobile pages 4-6).

A complementary dataset-level 2024 study reports a plasmid-encoded **type IV-A3** system that **lacks its own adaptation module** and instead **co-opts host type I-E adaptation** to acquire spacers in trans, and can interfere with plasmids/phages via **CRISPR-RNA-dependent transcriptional repression** (benz2024typeiva3crisprcas pages 1-3). This is a key boundary case for the trait because it demonstrates CRISPR modules functioning outside the canonical “cleavage-based immunity” frame.

### 3) Current applications and real-world implementations

#### Genome editing tool discovery and bioprospecting (environmental genomes)
A 2024 *Nature* study recovered **43,191 bacterial and archaeal genomes** from marine metagenomes (138 phyla) and used this catalogue for in silico bioprospecting, reporting discovery of a **novel CRISPR–Cas9 system** among other bioactives with **in vitro validation** (chen2024globalmarinemicrobial pages 1-2). This is a concrete “real-world implementation” pipeline: large-scale environmental genome recovery → CRISPR effector discovery → experimental validation.

#### CRISPR-based control of plasmid-borne traits (e.g., antibiotic resistance)
Plasmid-encoded type IV-A3 systems were reported to target conjugative plasmids and reduce plasmid uptake/transfer via transcriptional repression, with the authors noting potential programming to **re-sensitize bacteria to antibiotics** through plasmid destabilization (benz2024typeiva3crisprcas pages 1-3). This provides a mechanistic bridge from CRISPR presence to population-level outcomes relevant to AMR dissemination.

#### Safety/precision controls via anti-CRISPRs
Anti-CRISPR proteins are increasingly treated as tunable inhibitors (“off switches”) for CRISPR effectors in biotechnology. Mechanistically grounded examples include blocking PAM recognition (AcrIIC5), blocking Cascade target recognition (AcrIF1), and turning off type III second-messenger RNase cascades by degrading cA4 (AcrIII-1) (sun2023anticrispracriic5is pages 1-2, allemailem2024currentupdatesof pages 12-14, allemailem2024currentupdatesof pages 14-16).

### 4) Expert opinions / analysis from authoritative sources (mechanistic and ecological interpretation)

#### Ecological selection and uneven distribution
A 2024 ecological analysis emphasizes CRISPR–Cas as the only known adaptive immune system in prokaryotes but unevenly distributed across taxa and environments, noting high prevalence among thermophiles/archaea and lower prevalence among mesophilic bacteria (xiao2024ecologicaldriversof pages 1-2). The same work highlights that CRISPR can impose costs upon infection (induction and time lag), and that ecological factors such as density, diversity, nutrient limitation, and phage exposure can shift selection among resistance strategies (xiao2024ecologicaldriversof pages 1-2).

A 2024 modeling + experimental study provides a mechanistic population-genetic framing: successful invasion/spread of CRISPR-Cas into a population depends on **phage abundance** and the **difference in frequency of resistance phenotypes** between CRISPR+ and CRISPR– subpopulations; the model was tested experimentally in *Pseudomonas aeruginosa* with phage DMS3vir (elliott2024conditionsforthe pages 1-2).

#### MGEs as both antagonists and CRISPR “users”
A 2024 synthesis argues that CRISPR systems are not solely host defenses; MGEs can recruit CRISPR for counter-defense, competition, and integration functions (koonin2024crisprinmobile pages 1-2). For TraitMech curation, this means “CRISPR-Cas system present” should not automatically imply “host antiphage immunity”; some systems benefit plasmids/phages (e.g., anti-defense CRISPRs, inter-plasmid competition CRISPRs).

### 5) Relevant recent statistics and data (2023–2024 emphasized)

#### Prevalence across domains and environments
- Broad prevalence estimates (reviewed): **~40% of bacteria** and **~90% of archaea** encode CRISPR-Cas (oh2024harnessingcrisprcasadaptation pages 1-2, elliott2024conditionsforthe pages 1-2).
- Environmental contrast: CRISPR is described as common in **~90% of sequenced bacterial thermophiles and archaea** but **~40% of mesophilic bacteria** (xiao2024ecologicaldriversof pages 1-2).

#### Cold-adapted bacteria (large-scale 2024 survey)
A 2024 survey of **938 cold-adapted bacterial genomes** reports:
- **CRISPR-Cas in 17.7% (166/938) genomes**.
- Types **I, III, II** dominate; IV–VI rare.
- **Subtype II-C** was most frequent (52 II-C systems across 48 genomes) (sandsdalen2024exploringthefrozen pages 4-6).
These data support environment-associated nodes (temperature/cold habitat) affecting CRISPR incidence, but the relationship is correlative.

#### Species-level genome survey (Salmonella)
A 2024 analysis of **316 *Salmonella enterica* genomes** reports:
- **82.33% complete CRISPR-Cas**, **17.66% orphan CRISPRs**.
- Complete-system strains had **higher incidence of antibiotic resistance genes (ARGs)** (54.3% higher than strains without CRISPR-Cas; 15.1% higher than strains with orphan CRISPRs; weak but significant correlation, P = 3.892e–06) (fallah2024comprehensiveanalysisof pages 1-2).
This association is not sufficient to curate a causal edge without additional mechanistic evidence and controls.

#### Marine genome-resolved metagenomics and trade-offs
The 2024 global marine genome catalogue (43,191 genomes) reports a **trade-off between the occurrence of CRISPR–Cas systems and antibiotic resistance genes** and enables discovery of a novel Cas9 with experimental validation (chen2024globalmarinemicrobial pages 1-2). For curation, the trade-off is a high-value hypothesis node/edge but should be tagged uncertain until mechanistically resolved.

---

## Candidate nodes for causal graph (grouped)
| Node group | Candidate node | Suggested grounding | Notes for curation | Evidence |
|---|---|---|---|---|
| Trait/phenotype | CRISPR-Cas system | traitmech:000094 | Target trait; genomic capacity for adaptive immunity based on CRISPR arrays plus cas genes | (oh2024harnessingcrisprcasadaptation pages 1-2, cheng2024insightintothe pages 1-2) |
| Trait/phenotype | CRISPR repeat-spacer array |  | Structural locus component; do not equate alone with full CRISPR-Cas trait | (cheng2024insightintothe pages 1-2, sabri2024comprehensiveanalysisof pages 5-7) |
| Trait/phenotype | Orphan CRISPR array |  | Boundary case lacking cas genes; likely separate node/trait state | (fallah2024comprehensiveanalysisof pages 1-2) |
| Trait/phenotype | Degenerated terminal repeat |  | Array-decay/boundary-case feature rather than core trait-defining node | (sabri2024comprehensiveanalysisof pages 5-7) |
| Processes/modules | Spacer acquisition / adaptation | GO:0016567 | Core CRISPR adaptation process | (oh2024harnessingcrisprcasadaptation pages 1-2, cheng2024insightintothe pages 1-2) |
| Processes/modules | CRISPR array transcription |  | Upstream expression step producing pre-crRNA | (cheng2024insightintothe pages 1-2) |
| Processes/modules | pre-crRNA processing |  | Converts array transcript to mature guides; subtype-specific enzymes | (sabri2024comprehensiveanalysisof pages 5-7) |
| Processes/modules | crRNA-guided interference |  | Core target recognition/cleavage process | (oh2024harnessingcrisprcasadaptation pages 1-2, cheng2024insightintothe pages 1-2) |
| Processes/modules | RNA-derived spacer acquisition |  | Variant adaptation process in RT-associated systems | (oh2024harnessingcrisprcasadaptation pages 1-2) |
| Processes/modules | PAM recognition |  | Important targeting/self-nonself discrimination step in many DNA-targeting systems | (cheng2024insightintothe pages 1-2, sun2023anticrispracriic5is pages 1-2) |
| Processes/modules | cyclic oligoadenylate signaling |  | Type III accessory signaling process | (allemailem2024currentupdatesof pages 12-14, allemailem2024currentupdatesof pages 14-16) |
| Processes/modules | RNA-guided transcriptional repression |  | Noncanonical interference mode of type IV-A3 systems | (benz2024typeiva3crisprcas pages 1-3) |
| Processes/modules | RNA-guided site-specific transposition |  | CAST boundary-case process; related to CRISPR modules but distinct from canonical immunity | (koonin2024crisprinmobile pages 1-2) |
| Genes/proteins/complexes | Cas1 |  | Conserved adaptation integrase subunit | (oh2024harnessingcrisprcasadaptation pages 1-2, sabri2024comprehensiveanalysisof pages 5-7) |
| Genes/proteins/complexes | Cas2 |  | Conserved adaptation complex subunit | (oh2024harnessingcrisprcasadaptation pages 1-2, sabri2024comprehensiveanalysisof pages 5-7) |
| Genes/proteins/complexes | Cas4 |  | Accessory adaptation factor, especially PAM-compatible prespacer processing | (oh2024harnessingcrisprcasadaptation pages 1-2, sabri2024comprehensiveanalysisof pages 5-7) |
| Genes/proteins/complexes | Csn2 |  | Type II-associated adaptation factor | (sabri2024comprehensiveanalysisof pages 5-7) |
| Genes/proteins/complexes | RT-Cas1 fusion protein |  | Reverse-transcriptase-associated adaptation component for RNA-derived spacers | (oh2024harnessingcrisprcasadaptation pages 1-2) |
| Genes/proteins/complexes | Cas6 |  | pre-crRNA processing nuclease in many Class 1 systems | (sabri2024comprehensiveanalysisof pages 5-7) |
| Genes/proteins/complexes | RNase III |  | Type II pre-crRNA/tracrRNA processing factor | (sabri2024comprehensiveanalysisof pages 5-7) |
| Genes/proteins/complexes | tracrRNA |  | Type II guide-RNA maturation component | (sabri2024comprehensiveanalysisof pages 5-7) |
| Genes/proteins/complexes | crRNA |  | Mature guide RNA directing interference | (oh2024harnessingcrisprcasadaptation pages 1-2, elliott2024conditionsforthe pages 1-2) |
| Genes/proteins/complexes | pre-crRNA |  | Primary array transcript before processing | (cheng2024insightintothe pages 1-2, sabri2024comprehensiveanalysisof pages 5-7) |
| Genes/proteins/complexes | Cascade complex |  | Type I surveillance complex | (sabri2024comprehensiveanalysisof pages 5-7, allemailem2024currentupdatesof pages 10-12) |
| Genes/proteins/complexes | Csy complex |  | Type I-F surveillance complex label | (allemailem2024currentupdatesof pages 24-25) |
| Genes/proteins/complexes | Cas7 |  | Backbone subunit targeted by several Acrs | (allemailem2024currentupdatesof pages 12-14, allemailem2024currentupdatesof pages 10-12) |
| Genes/proteins/complexes | Cas8 |  | PAM-recognition subunit in type I complexes | (allemailem2024currentupdatesof pages 12-14, allemailem2024currentupdatesof pages 10-12) |
| Genes/proteins/complexes | Cas3 |  | Type I helicase-nuclease effector | (allemailem2024currentupdatesof pages 12-14, allemailem2024currentupdatesof pages 10-12) |
| Genes/proteins/complexes | Cas9 |  | Type II single-protein effector | (sabri2024comprehensiveanalysisof pages 5-7, sun2023anticrispracriic5is pages 1-2) |
| Genes/proteins/complexes | Cas9 HNH domain |  | Catalytic domain targeted by anti-CRISPRs | (allemailem2024currentupdatesof pages 16-18, sun2023anticrispracriic5is pages 1-2) |
| Genes/proteins/complexes | Cas9 RuvC domain |  | Catalytic domain involved in DNA cleavage and Acr interactions | (allemailem2024currentupdatesof pages 16-18, sun2023anticrispracriic5is pages 1-2) |
| Genes/proteins/complexes | Cas9 PI domain |  | PAM-interacting domain | (sun2023anticrispracriic5is pages 1-2) |
| Genes/proteins/complexes | Cas12 |  | Type V single-protein effector | (sabri2024comprehensiveanalysisof pages 5-7, allemailem2024currentupdatesof pages 16-18) |
| Genes/proteins/complexes | Cas13 |  | Type VI RNA-targeting effector | (sabri2024comprehensiveanalysisof pages 5-7, allemailem2024currentupdatesof pages 16-18) |
| Genes/proteins/complexes | HEPN RNase domains |  | Characteristic catalytic domains of Cas13 | (kenny2024molecularmechanismsof pages 22-25) |
| Genes/proteins/complexes | Csm complex |  | Type III effector complex label | (sabri2024comprehensiveanalysisof pages 5-7, allemailem2024currentupdatesof pages 12-14) |
| Genes/proteins/complexes | Cmr complex |  | Type III effector complex label | (sabri2024comprehensiveanalysisof pages 5-7, allemailem2024currentupdatesof pages 14-16) |
| Genes/proteins/complexes | Cas10 |  | Type III signaling subunit making cyclic oligoadenylates | (allemailem2024currentupdatesof pages 12-14) |
| Genes/proteins/complexes | Csm6 |  | cOA-activated accessory RNase | (allemailem2024currentupdatesof pages 12-14, allemailem2024currentupdatesof pages 14-16) |
| Genes/proteins/complexes | Csx1 |  | cOA-activated accessory RNase | (allemailem2024currentupdatesof pages 14-16) |
| Genes/proteins/complexes | CARF domain |  | cOA-sensing domain in accessory RNases | (allemailem2024currentupdatesof pages 12-14, allemailem2024currentupdatesof pages 14-16) |
| Genes/proteins/complexes | DinG helicase |  | Type IV-associated helicase replacing canonical nuclease | (koonin2024crisprinmobile pages 4-6, benz2024typeiva3crisprcas pages 1-3) |
| Inhibitors/counter-defense | Anti-CRISPR protein (general) |  | Generic counter-defense node; many families/subtype-specific mechanisms | (cheng2024insightintothe pages 1-2, allemailem2024currentupdatesof pages 12-14) |
| Inhibitors/counter-defense | AcrIF1 |  | Type I-F inhibitor that binds Cas7 | (allemailem2024currentupdatesof pages 12-14, allemailem2024currentupdatesof pages 10-12) |
| Inhibitors/counter-defense | AcrIF2 |  | Type I-F inhibitor that blocks PAM recognition region | (allemailem2024currentupdatesof pages 12-14, allemailem2024currentupdatesof pages 10-12) |
| Inhibitors/counter-defense | AcrIF3 |  | Type I-F inhibitor of Cas3 | (allemailem2024currentupdatesof pages 12-14, allemailem2024currentupdatesof pages 10-12) |
| Inhibitors/counter-defense | AcrIF9 |  | Type I-F inhibitor promoting non-specific dsDNA binding/sequestration | (allemailem2024currentupdatesof pages 12-14) |
| Inhibitors/counter-defense | AcrIF11 |  | Type I-F inhibitor modifying Cas8 | (allemailem2024currentupdatesof pages 12-14) |
| Inhibitors/counter-defense | Racr repeat-mimic RNA |  | RNA anti-CRISPR; solitary repeat unit mimic | (camarawilpert2023bacteriophagessuppresscrispr–cas pages 1-2) |
| Inhibitors/counter-defense | AcrIII-1 |  | Ring nuclease anti-CRISPR degrading cA4 | (allemailem2024currentupdatesof pages 14-16) |
| Inhibitors/counter-defense | AcrIIC1 |  | Type II-C Cas9 HNH inhibitor | (allemailem2024currentupdatesof pages 16-18, sun2023anticrispracriic5is pages 1-2) |
| Inhibitors/counter-defense | AcrIIC2 |  | Type II-C inhibitor preventing guide-RNA loading | (sun2023anticrispracriic5is pages 1-2) |
| Inhibitors/counter-defense | AcrIIC5 |  | dsDNA-mimic inhibitor blocking PAM recognition | (sun2023anticrispracriic5is pages 1-2) |
| Inhibitors/counter-defense | AcrIIA4 |  | Cas9 inhibitor blocking target recognition/cleavage | (allemailem2024currentupdatesof pages 14-16, allemailem2024currentupdatesof pages 16-18) |
| Inhibitors/counter-defense | AcrVA1 |  | Cas12a inhibitor with crRNA cleavage activity | (allemailem2024currentupdatesof pages 16-18) |
| Inhibitors/counter-defense | AcrVA4 |  | Cas12a inhibitor promoting inactive dimerization/conformational block | (allemailem2024currentupdatesof pages 16-18) |
| Inhibitors/counter-defense | AcrVA5 |  | Cas12a inhibitor via acetylation | (allemailem2024currentupdatesof pages 16-18) |
| Mobile genetic elements | Bacteriophage |  | Major invader/selection pressure; also encodes Acrs and some CRISPRs | (oh2024harnessingcrisprcasadaptation pages 1-2, koonin2024crisprinmobile pages 1-2) |
| Mobile genetic elements | Plasmid |  | Invader and frequent carrier of type IV systems | (oh2024harnessingcrisprcasadaptation pages 1-2, benz2024typeiva3crisprcas pages 1-3) |
| Mobile genetic elements | Prophage |  | Common spacer target in some natural populations | (camarawilpert2023bacteriophagessuppresscrispr–cas pages 1-2) |
| Mobile genetic elements | Type IV CRISPR-Cas system |  | MGE-linked atypical CRISPR class | (koonin2024crisprinmobile pages 4-6, koonin2024crisprinmobile pages 1-2) |
| Mobile genetic elements | Type IV-A3 CRISPR-Cas system |  | Plasmid-encoded subtype co-opting host adaptation machinery | (benz2024typeiva3crisprcas pages 1-3) |
| Mobile genetic elements | CRISPR-associated transposon (CAST) |  | MGE using CRISPR guidance for transposition | (koonin2024crisprinmobile pages 1-2) |
| Mobile genetic elements | Tn7-like transposon |  | Frequent CAST backbone | (koonin2024crisprinmobile pages 1-2) |
| Mobile genetic elements | Mu-like transposon |  | Additional CRISPR-associated transposon context | (koonin2024crisprinmobile pages 1-2) |
| Mobile genetic elements | Casposon |  | Evolutionarily linked MGE with Cas1-like transposase; boundary case | (rentz2024genomicmobilitytransposons pages 6-8) |
| Environmental/ecological factors | Phage abundance / phage exposure |  | Major ecological driver of CRISPR selection dynamics | (xiao2024ecologicaldriversof pages 1-2, elliott2024conditionsforthe pages 1-2) |
| Environmental/ecological factors | Host population abundance / taxon abundance |  | Marine ecological correlate of CRISPR incidence | (xiao2024ecologicaldriversof pages 1-2) |
| Environmental/ecological factors | Community diversity |  | Oral-environment correlate of CRISPR incidence | (xiao2024ecologicaldriversof pages 1-2) |
| Environmental/ecological factors | Nutrient concentration |  | Lower nutrients can favor inducible CRISPR defenses | (xiao2024ecologicaldriversof pages 1-2) |
| Environmental/ecological factors | Temperature |  | Major macroecological correlate of CRISPR prevalence | (xiao2024ecologicaldriversof pages 1-2, sandsdalen2024exploringthefrozen pages 1-2) |
| Environmental/ecological factors | Marine environment | ENVO:00000015 | Environment where abundance effects were examined | (xiao2024ecologicaldriversof pages 1-2, chen2024globalmarinemicrobial pages 1-2) |
| Environmental/ecological factors | Human oral environment | ENVO:00002042 | Diversity-linked CRISPR incidence context | (xiao2024ecologicaldriversof pages 1-2) |
| Environmental/ecological factors | Cold environment / psychrophilic habitat |  | Cold-adapted bacterial survey context | (sandsdalen2024exploringthefrozen pages 4-6, sandsdalen2024exploringthefrozen pages 1-2) |
| Environmental/ecological factors | Thermophilic lifestyle |  | High CRISPR prevalence context | (xiao2024ecologicaldriversof pages 1-2) |
| Environmental/ecological factors | Mesophilic lifestyle |  | Lower CRISPR prevalence context relative to thermophiles/archaea | (xiao2024ecologicaldriversof pages 1-2) |
| Environmental/ecological factors | Antibiotic pressure |  | Proposed ecological/evolutionary driver in some species studies; mostly correlative | (fallah2024comprehensiveanalysisof pages 1-2, chen2024globalmarinemicrobial pages 1-2) |
| Chemicals/signals | cyclic tetra-adenylate (cA4) | CHEBI: not clearly established here | Type III second messenger degraded by AcrIII-1 | (allemailem2024currentupdatesof pages 12-14, allemailem2024currentupdatesof pages 14-16) |
| Chemicals/signals | cyclic hexa-adenylate (cA6) | CHEBI: not clearly established here | Alternative Type III cyclic oligoadenylate signal | (allemailem2024currentupdatesof pages 14-16) |
| Chemicals/signals | PAM sequence |  | Short target-adjacent DNA motif important for discrimination/targeting | (cheng2024insightintothe pages 1-2, sun2023anticrispracriic5is pages 1-2) |
| Chemicals/signals | Protospacer |  | Invader-derived sequence source/target complement | (cheng2024insightintothe pages 1-2, elliott2024conditionsforthe pages 1-2) |
| Chemicals/signals | Spacer |  | Integrated immune memory element in CRISPR arrays | (oh2024harnessingcrisprcasadaptation pages 1-2, elliott2024conditionsforthe pages 1-2) |
| Chemicals/signals | Double-stranded DNA | CHEBI:16991 | Target substrate mimicked by AcrIIC5 in Type II-C inhibition | (sun2023anticrispracriic5is pages 1-2) |
| Chemicals/signals | Target RNA | CHEBI:33697 | Substrate for Cas13 and some Type III responses | (sabri2024comprehensiveanalysisof pages 5-7, allemailem2024currentupdatesof pages 16-18) |


*Table: This table lists candidate nodes for a TraitMech-style CRISPR-Cas causal graph, grouped by biological type and annotated with suggested ontology grounding where clear. It is useful as a curation scaffold for selecting graph entities before adding evidence-backed edges.*

---

## Evidence-backed candidate causal edges (triples)
| Edge (S–P–O) | Node type(s) | Evidence snippet (short quote) | Reference (DOI, year, URL) | Curation notes |
|---|---|---|---|---|
| Cas1–Cas2 complex → integrates into → CRISPR array spacers | protein complex → biological process/sequence feature | “Cas1-Cas2 complexes function as molecular recorders to integrate spacers” (oh2024harnessingcrisprcasadaptation pages 1-2) | 10.5483/bmbrep.2023-0050, 2024, https://doi.org/10.5483/bmbrep.2023-0050 | Core adaptation edge; broad across canonical CRISPR-Cas systems. Strong curation candidate. |
| RT–Cas1 fusion protein → enables acquisition of → RNA-derived spacers | fusion protein → biological process | “RT enables spacer acquisition from RNA molecules” (oh2024harnessingcrisprcasadaptation pages 1-2) | 10.5483/bmbrep.2023-0050, 2024, https://doi.org/10.5483/bmbrep.2023-0050 | Variant-system edge; strong but limited to RT-associated systems (types III/VI variants). Mark taxon/system-specific. |
| CRISPR array transcription/processing → produces → crRNA | biological process → RNA | “CRISPR arrays transcribed and processed into crRNAs” (cheng2024insightintothe pages 1-2) | 10.1016/j.heliyon.2024.e39538, 2024, https://doi.org/10.1016/j.heliyon.2024.e39538 | General edge across systems; exact processing enzymes vary by subtype. |
| Cas6 or RNase III → processes → pre-crRNA | enzyme/protein → RNA processing | “pre-crRNA processing = Cas6 or RNase III/trimming” (sabri2024comprehensiveanalysisof pages 5-7) | 10.25163/microbbioacts.719376, 2024, https://doi.org/10.25163/microbbioacts.719376 | Subtype-dependent: Cas6 common in many Class 1 systems; RNase III especially Type II with tracrRNA. Mark subtype-specific. |
| crRNA–Cas effector complex → cleaves → invading nucleic acid target | ribonucleoprotein complex → nucleic acid | “effector-crRNA complexes for the RNA-guided interference pathways” (oh2024harnessingcrisprcasadaptation pages 1-2) | 10.5483/bmbrep.2023-0050, 2024, https://doi.org/10.5483/bmbrep.2023-0050 | High-level interference edge; target modality depends on system type (DNA vs RNA). |
| Type I/II/IV/V CRISPR-Cas systems → target → DNA | system class/type → nucleic acid | “types I/II/IV/V are DNA-targeting” (oh2024harnessingcrisprcasadaptation pages 1-2) | 10.5483/bmbrep.2023-0050, 2024, https://doi.org/10.5483/bmbrep.2023-0050 | Useful classification edge; broad but abstract. |
| Type III/VI CRISPR-Cas systems → target → RNA | system class/type → nucleic acid | “III/VI are RNA-targeting” (oh2024harnessingcrisprcasadaptation pages 1-2) | 10.5483/bmbrep.2023-0050, 2024, https://doi.org/10.5483/bmbrep.2023-0050 | Useful classification edge; broad but abstract. |
| Cas9 → cannot directly target → RNA | protein → nucleic acid | “Cas9 is unable to interact directly with RNA” (sabri2024comprehensiveanalysisof pages 5-7) | 10.25163/microbbioacts.719376, 2024, https://doi.org/10.25163/microbbioacts.719376 | Negative constraint edge; good for boundary conditions of Type II systems. |
| Cas9/Cas3-mediated chromosomal breakage → causes → cell death | molecular process/protein activity → phenotype | “chromosomal breakage and consequent cell death” (sabri2024comprehensiveanalysisof pages 5-7) | 10.25163/microbbioacts.719376, 2024, https://doi.org/10.25163/microbbioacts.719376 | Mechanistic outcome edge; mostly relevant when self-targeting or antimicrobial retargeting occurs. Mark context-dependent. |
| Cas13 effector → cleaves → target RNA | protein → RNA | “Sequence-specific Rnase activity” (sabri2024comprehensiveanalysisof pages 5-7) | 10.25163/microbbioacts.719376, 2024, https://doi.org/10.25163/microbbioacts.719376 | Strong Type VI edge. |
| Type III Csm/Cmr complex → synthesizes → cyclic oligoadenylate (cOA) | protein complex → small molecule | “Csm/Cmr synthesize cOA” (allemailem2024currentupdatesof pages 12-14) | 10.2147/IJN.S479068, 2024, https://doi.org/10.2147/ijn.s479068 | Strong signaling edge for Type III systems; subtype-specific. |
| cyclic oligoadenylate (cA4/cA6) → activates → Csm6/Csx1 RNase | small molecule → protein/RNase activity | “activates Csm6 RNase via the CARF domain” (allemailem2024currentupdatesof pages 12-14) | 10.2147/IJN.S479068, 2024, https://doi.org/10.2147/ijn.s479068 | Strong Type III accessory defense edge; curate with subtype specificity. |
| AcrIII-1 ring nuclease → degrades → cA4 | inhibitor enzyme → signaling molecule | “AcrIII-1 bind[s]/degrade[s] cA4” (allemailem2024currentupdatesof pages 14-16) | 10.2147/IJN.S479068, 2024, https://doi.org/10.2147/ijn.s479068 | Clear anti-CRISPR inhibition edge; specific to cOA-dependent systems. |
| AcrIF1 → binds → Cas7 (Cascade) | inhibitor protein → CRISPR effector subunit | “AcrIF1 binds Cas7” (allemailem2024currentupdatesof pages 12-14) | 10.2147/IJN.S479068, 2024, https://doi.org/10.2147/ijn.s479068 | Strong molecular inhibition edge; Type I-F specific. |
| AcrIF1 binding to Cas7 → inhibits → crRNA–DNA hybridization | inhibitor mechanism → molecular process | “sterically obstructing crRNA–DNA hybridization” (allemailem2024currentupdatesof pages 12-14) | 10.2147/IJN.S479068, 2024, https://doi.org/10.2147/ijn.s479068 | Mechanistic downstream edge; subtype-specific. |
| AcrIF3 → inhibits → Cas3 nuclease activity/recruitment | inhibitor protein → nuclease/protein | “AcrIF3… bind and inactivate Cas3” (allemailem2024currentupdatesof pages 12-14) | 10.2147/IJN.S479068, 2024, https://doi.org/10.2147/ijn.s479068 | Strong anti-CRISPR edge for Type I. |
| Racr repeat-mimic RNA → binds → Cas6f/Cas7f | inhibitory RNA → CRISPR proteins | “binding Cas proteins Cas6f and Cas7f” (camarawilpert2023bacteriophagessuppresscrispr–cas pages 1-2) | 10.1038/s41586-023-06612-5, 2023, https://doi.org/10.1038/s41586-023-06612-5 | Strong RNA anti-CRISPR edge; Type I-F example but broader candidate across types is inferential. |
| Racr repeat-mimic RNA → disrupts → effector complex assembly | inhibitory RNA → molecular process | “producing an aberrant Cas subcomplex” (camarawilpert2023bacteriophagessuppresscrispr–cas pages 1-2) | 10.1038/s41586-023-06612-5, 2023, https://doi.org/10.1038/s41586-023-06612-5 | Good inhibition edge; likely specific to matched host system. |
| AcrIIC5 → blocks → PAM recognition by Cas9 | inhibitor protein → molecular function | “occlude[s] the protospacer adjacent motif (PAM) binding site” (sun2023anticrispracriic5is pages 1-2) | 10.1093/nar/gkad052, 2023, https://doi.org/10.1093/nar/gkad052 | Strong Type II-C anti-CRISPR edge; subtype-specific. |
| AcrIIC2 → prevents → guide RNA loading into Cas9 | inhibitor protein → assembly process | “AcrIIC2 binds to the… BH domain and prevents guide RNA loading” (sun2023anticrispracriic5is pages 1-2) | 10.1093/nar/gkad052, 2023, https://doi.org/10.1093/nar/gkad052 | Strong Type II-C edge; specific to certain Cas9 orthologs. |
| AcrIIC1 → inhibits → Cas9 HNH nuclease activity | inhibitor protein → nuclease activity | “AcrIIC1 binds to the catalytic sites in the HNH nuclease domain” (sun2023anticrispracriic5is pages 1-2) | 10.1093/nar/gkad052, 2023, https://doi.org/10.1093/nar/gkad052 | Strong inhibitory edge; Type II-C focused. |
| phage/plasmid pressure → selects for → CRISPR-Cas immunity | environmental factor → trait | “protect hosts from the invasion of foreign enemies, such as bacteriophages and plasmids” (oh2024harnessingcrisprcasadaptation pages 1-2) | 10.5483/bmbrep.2023-0050, 2024, https://doi.org/10.5483/bmbrep.2023-0050 | Broad ecological edge; mechanistically well accepted but not a direct causal test in this quote alone. Moderate confidence. |
| increasing phage exposure → selects against → CRISPR relative to surface defenses | environmental factor → trait outcome | “increasing phage exposure selected against CRISPR relative to surface-modification defenses” (xiao2024ecologicaldriversof pages 1-2) | 10.1128/msystems.00568-24, 2024, https://doi.org/10.1128/msystems.00568-24 | Ecological edge with context dependence; avoid overgeneralizing across habitats. |
| lower nutrient concentration / lower host density → favors → CRISPR defenses | environmental factor → trait outcome | “lower nutrient concentrations… favor inducible CRISPR defenses” (xiao2024ecologicaldriversof pages 1-2) | 10.1128/msystems.00568-24, 2024, https://doi.org/10.1128/msystems.00568-24 | Experimental/ecological driver; may be system- and environment-dependent. |
| higher community diversity → correlates with → CRISPR incidence | community property → trait | “CRISPR incidence is strongly positively correlated with taxonomic diversity” (xiao2024ecologicaldriversof pages 1-2) | 10.1128/msystems.00568-24, 2024, https://doi.org/10.1128/msystems.00568-24 | Correlative, human oral environment-specific; mark uncertain for broad curation. |
| lower taxon abundance in marine environments → favors → CRISPR incidence | abundance/environment factor → trait | “CRISPR systems are significantly favored in lower-abundance… taxa” (xiao2024ecologicaldriversof pages 1-2) | 10.1128/msystems.00568-24, 2024, https://doi.org/10.1128/msystems.00568-24 | Correlative and habitat-specific (marine). Mark uncertain. |
| phage abundance + higher resistance-frequency difference in CRISPR+ cells → promotes spread of → CRISPR-Cas into populations | ecological/evolutionary factor → population trait | “spread depends on phage abundance and the difference in frequency of phage-resistance mechanisms” (elliott2024conditionsforthe pages 1-2) | 10.1093/ismejo/wrae108, 2024, https://doi.org/10.1093/ismejo/wrae108 | Model- and experiment-supported population edge; useful but not a direct intracellular mechanism. |
| Type IV-A3 CRISPR-Cas → co-opts → host Type I-E adaptation machinery | CRISPR system → protein module | “co-opt the type I-E adaptation machinery” (benz2024typeiva3crisprcas pages 1-3) | 10.5061/dryad.8pk0p2nvp, 2024, https://doi.org/10.5061/dryad.8pk0p2nvp | Strong edge for MGE-encoded Type IV-A3; narrow scope. |
| Type IV-A3 CRISPR-Cas → represses transcription of → plasmid core functions | CRISPR system → gene function/process | “CRISPR RNA-dependent transcriptional repression” and “silences ‘plasmid core functions’” (benz2024typeiva3crisprcas pages 1-3) | 10.5061/dryad.8pk0p2nvp, 2024, https://doi.org/10.5061/dryad.8pk0p2nvp | Important noncanonical interference edge; plasmid-specific. |
| repression of plasmid core functions → reduces → horizontal plasmid transfer/stability | process → phenotype | “reducing the horizontal transfer and stability of targeted plasmids” (benz2024typeiva3crisprcas pages 1-3) | 10.5061/dryad.8pk0p2nvp, 2024, https://doi.org/10.5061/dryad.8pk0p2nvp | Strong downstream outcome edge; specific to studied Type IV-A3 plasmids. |
| plasmid-encoded type IV/subtype V-M CRISPR systems → mediate → inter-plasmid competition | MGE-encoded system → ecological interaction | “Plasmids frequently encode type IV or subtype V-M CRISPR systems implicated in inter-plasmid competition” (koonin2024crisprinmobile pages 1-2) | 10.1186/s12915-024-02090-x, 2024, https://doi.org/10.1186/s12915-024-02090-x | High-value ecological edge; broad review-level summary, mechanism varies by subtype. |
| CAST CRISPR modules → direct → RNA-guided site-specific transposition | CRISPR-associated transposon module → process | “mediate RNA-guided, site-specific transposition” (koonin2024crisprinmobile pages 1-2) | 10.1186/s12915-024-02090-x, 2024, https://doi.org/10.1186/s12915-024-02090-x | Important boundary-case edge showing CRISPR function beyond immunity; curate separately from canonical immunity if ontology distinguishes. |
| cold-adapted bacterial lifestyle → associates with lower prevalence of → CRISPR-Cas systems | environment/lifestyle → trait | “CRISPR-Cas loci were present in 17.7%” and are “less frequent in cold-adapted bacteria” (sandsdalen2024exploringthefrozen pages 4-6, sandsdalen2024exploringthefrozen pages 1-2) | 10.3390/microorganisms12051028, 2024, https://doi.org/10.3390/microorganisms12051028 | Quantitative environment-associated edge; correlative, not mechanistic. |
| complete CRISPR-Cas system in Salmonella enterica → associates with higher incidence of → antibiotic resistance genes | trait → genomic phenotype | “54.3% higher than strains without CRISPR-Cas” (fallah2024comprehensiveanalysisof pages 1-2) | 10.1177/11779322241307984, 2024, https://doi.org/10.1177/11779322241307984 | Correlation only; species-specific and potentially confounded. Do not curate as causal without stronger evidence. |
| marine microbial genomes with CRISPR–Cas occurrence → show trade-off with → antibiotic resistance genes | trait/genome property → genome property | “trade-off between the occurrence of CRISPR–Cas systems and antibiotic resistance genes” (chen2024globalmarinemicrobial pages 1-2) | 10.1038/s41586-024-07891-2, 2024, https://doi.org/10.1038/s41586-024-07891-2 | High-interest ecological/genomic association; mechanistic basis not established in excerpt. Mark uncertain. |


*Table: This table lists candidate subject–predicate–object edges for a TraitMech CRISPR-Cas causal graph, using only the specified evidence contexts. It emphasizes core adaptation, processing, interference, anti-CRISPR inhibition, mobile-element variants, and environment-associated drivers while flagging scope and uncertainty for curation.*

---

## Bibliography (DOI-first; publication dates and URLs)

1. Oh G-S, An S, Kim S. **Harnessing CRISPR-Cas adaptation for RNA recording and beyond**. *BMB Reports*. **2024-01**. DOI: **10.5483/bmbrep.2023-0050**. URL: https://doi.org/10.5483/bmbrep.2023-0050 (oh2024harnessingcrisprcasadaptation pages 1-2)
2. Cheng H, Deng H, Ma D, et al. **Insight into the natural regulatory mechanisms and clinical applications of the CRISPR-Cas system**. *Heliyon*. **2024-10**. DOI: **10.1016/j.heliyon.2024.e39538**. URL: https://doi.org/10.1016/j.heliyon.2024.e39538 (cheng2024insightintothe pages 1-2)
3. Xiao W, Weissman JL, Johnson PLF. **Ecological drivers of CRISPR immune systems**. *mSystems*. **2024-12**. DOI: **10.1128/msystems.00568-24**. URL: https://doi.org/10.1128/msystems.00568-24 (xiao2024ecologicaldriversof pages 1-2)
4. Elliott JFK, McLeod DV, Taylor TB, Westra ER, Gandon S, Watson BNJ. **Conditions for the spread of CRISPR-Cas immune systems into bacterial populations**. *The ISME Journal*. **2024-01**. DOI: **10.1093/ismejo/wrae108**. URL: https://doi.org/10.1093/ismejo/wrae108 (elliott2024conditionsforthe pages 1-2)
5. Sandsdalen GD, Kumar A, Hjerde E. **Exploring the Frozen Armory: Antiphage Defense Systems in Cold-Adapted Bacteria with a Focus on CRISPR-Cas Systems**. *Microorganisms*. **2024-05**. DOI: **10.3390/microorganisms12051028**. URL: https://doi.org/10.3390/microorganisms12051028 (sandsdalen2024exploringthefrozen pages 4-6, sandsdalen2024exploringthefrozen pages 1-2)
6. Fallah T, Shafiei M. **Comprehensive Analysis of CRISPR-Cas Systems and Their Influence on Antibiotic Resistance in Salmonella enterica Strains**. *Bioinformatics and Biology Insights*. **2024-01**. DOI: **10.1177/11779322241307984**. URL: https://doi.org/10.1177/11779322241307984 (fallah2024comprehensiveanalysisof pages 1-2)
7. Chen J, Jia Y, Sun Y, et al. **Global marine microbial diversity and its potential in bioprospecting**. *Nature*. **2024-09**. DOI: **10.1038/s41586-024-07891-2**. URL: https://doi.org/10.1038/s41586-024-07891-2 (chen2024globalmarinemicrobial pages 1-2)
8. Koonin EV, Makarova KS. **CRISPR in mobile genetic elements: counter-defense, inter-element competition and RNA-guided transposition**. *BMC Biology*. **2024-12**. DOI: **10.1186/s12915-024-02090-x**. URL: https://doi.org/10.1186/s12915-024-02090-x (koonin2024crisprinmobile pages 1-2, koonin2024crisprinmobile pages 4-6)
9. Benz F, Camara-Wilpert S, Russel J, et al. **Type IV-A3 CRISPR-Cas systems drive inter-plasmid conflicts by acquiring spacers in trans**. *Dryad dataset*. **2024-04**. DOI: **10.5061/dryad.8pk0p2nvp**. URL: https://doi.org/10.5061/dryad.8pk0p2nvp (benz2024typeiva3crisprcas pages 1-3)
10. Camara-Wilpert S, Mayo-Muñoz D, Russel J, et al. **Bacteriophages suppress CRISPR–Cas immunity using RNA-based anti-CRISPRs**. *Nature*. **2023-10**. DOI: **10.1038/s41586-023-06612-5**. URL: https://doi.org/10.1038/s41586-023-06612-5 (camarawilpert2023bacteriophagessuppresscrispr–cas pages 1-2)
11. Sun W, Zhao X, Wang J, et al. **Anti-CRISPR AcrIIC5 is a dsDNA mimic that inhibits type II-C Cas9 effectors by blocking PAM recognition**. *Nucleic Acids Research*. **2023-02**. DOI: **10.1093/nar/gkad052**. URL: https://doi.org/10.1093/nar/gkad052 (sun2023anticrispracriic5is pages 1-2)
12. Allemailem K, Almatroudi A, Alrumaihi F, et al. **Current Updates of CRISPR/Cas System and Anti-CRISPR Proteins: Innovative Applications to Improve the Genome Editing Strategies**. *International Journal of Nanomedicine*. **2024-10**. DOI: **10.2147/IJN.S479068**. URL: https://doi.org/10.2147/IJN.S479068 (allemailem2024currentupdatesof pages 12-14, allemailem2024currentupdatesof pages 14-16, allemailem2024currentupdatesof pages 10-12, allemailem2024currentupdatesof pages 16-18)

---

## Warnings / “do not curate yet” items

1. **Correlative ecology edges**: Several links (e.g., CRISPR incidence vs marine taxon abundance; oral diversity correlation; cold-environment prevalence) are supported by observational analyses and should be curated as **associations** or **uncertain causal edges** unless complemented with mechanistic/experimental support in the specific target context (xiao2024ecologicaldriversof pages 1-2, sandsdalen2024exploringthefrozen pages 4-6).
2. **CRISPR–ARG relationships**: The *Salmonella* association (complete CRISPR-Cas ↔ higher ARG incidence) and the marine trade-off (CRISPR–Cas ↔ antibiotic resistance gene occurrence) should **not** be curated as direct causal edges without stronger causal inference and controls for population structure, mobile element load, sampling, and confounding (fallah2024comprehensiveanalysisof pages 1-2, chen2024globalmarinemicrobial pages 1-2).
3. **MGE-encoded CRISPRs**: Because MGEs can encode CRISPR systems that benefit the MGE rather than the host (anti-defense, inter-plasmid competition, CAST transposition), curations should explicitly label the **carrier context** (chromosome vs plasmid vs phage vs transposon) and avoid assuming “host immunity” as the sole outcome (koonin2024crisprinmobile pages 1-2, benz2024typeiva3crisprcas pages 1-3).
4. **Anti-CRISPR generalization across types**: Mechanisms (AcrIF1/Cas7, AcrIIC5/PAM blockade, Racr/Cas6f-Cas7f) are often subtype-specific; cross-type generalization should be marked **uncertain** unless supported by direct evidence in the target type (allemailem2024currentupdatesof pages 12-14, camarawilpert2023bacteriophagessuppresscrispr–cas pages 1-2, sun2023anticrispracriic5is pages 1-2).

References

1. (oh2024harnessingcrisprcasadaptation pages 1-2): Gyeong-Seok Oh, Seongjin An, and Sungchul Kim. Harnessing crispr-cas adaptation for rna recording and beyond. BMB Reports, 57:40-49, Jan 2024. URL: https://doi.org/10.5483/bmbrep.2023-0050, doi:10.5483/bmbrep.2023-0050. This article has 3 citations and is from a peer-reviewed journal.

2. (cheng2024insightintothe pages 1-2): Hui Cheng, Haoyue Deng, Dongdao Ma, Mengyuan Gao, Zhihan Zhou, Heng Li, Shejuan Liu, and Tieshan Teng. Insight into the natural regulatory mechanisms and clinical applications of the crispr-cas system. Heliyon, 10:e39538, Oct 2024. URL: https://doi.org/10.1016/j.heliyon.2024.e39538, doi:10.1016/j.heliyon.2024.e39538. This article has 6 citations.

3. (fallah2024comprehensiveanalysisof pages 1-2): Tina Fallah and Morvarid Shafiei. Comprehensive analysis of crispr-cas systems and their influence on antibiotic resistance in salmonella enterica strains. Bioinformatics and Biology Insights, Jan 2024. URL: https://doi.org/10.1177/11779322241307984, doi:10.1177/11779322241307984. This article has 3 citations and is from a peer-reviewed journal.

4. (sabri2024comprehensiveanalysisof pages 5-7): S Sabri, MK Mustofa, and MT Fouad. Comprehensive analysis of crispr-cas systems in microbial and their multifaceted applications. Microbial Bioactives, May 2024. URL: https://doi.org/10.25163/microbbioacts.719376, doi:10.25163/microbbioacts.719376. This article has 5 citations.

5. (koonin2024crisprinmobile pages 4-6): Eugene V. Koonin and Kira S. Makarova. Crispr in mobile genetic elements: counter-defense, inter-element competition and rna-guided transposition. BMC Biology, Dec 2024. URL: https://doi.org/10.1186/s12915-024-02090-x, doi:10.1186/s12915-024-02090-x. This article has 18 citations and is from a domain leading peer-reviewed journal.

6. (benz2024typeiva3crisprcas pages 1-3): F. Benz, S. Camara-Wilpert, Jakob Russel, Katharina G. Wandera, R. Čepaitė, Manuel Ares-Arroyo, J. Gomes-Filho, Frank Englert, Johannes A Kuehn, Silvana Gloor, A. Cuénod, Mònica Aguilà-Sans, Lorrie Maccario, A. Egli, Lennart Randau, P. Pausch, E. Rocha, Chase L. Beisel, J. Madsen, David Bikard, A. Hall, S. Sørensen, and R. Pinilla-Redondo. Type iv-a3 crispr-cas systems drive inter-plasmid conflicts by acquiring spacers in trans. Apr 2024. URL: https://doi.org/10.5061/dryad.8pk0p2nvp, doi:10.5061/dryad.8pk0p2nvp. This article has 44 citations.

7. (koonin2024crisprinmobile pages 1-2): Eugene V. Koonin and Kira S. Makarova. Crispr in mobile genetic elements: counter-defense, inter-element competition and rna-guided transposition. BMC Biology, Dec 2024. URL: https://doi.org/10.1186/s12915-024-02090-x, doi:10.1186/s12915-024-02090-x. This article has 18 citations and is from a domain leading peer-reviewed journal.

8. (camarawilpert2023bacteriophagessuppresscrispr–cas pages 1-2): Sarah Camara-Wilpert, David Mayo-Muñoz, Jakob Russel, Robert D. Fagerlund, Jonas S. Madsen, Peter C. Fineran, Søren J. Sørensen, and Rafael Pinilla-Redondo. Bacteriophages suppress crispr–cas immunity using rna-based anti-crisprs. Nature, 623:601-607, Oct 2023. URL: https://doi.org/10.1038/s41586-023-06612-5, doi:10.1038/s41586-023-06612-5. This article has 94 citations and is from a highest quality peer-reviewed journal.

9. (sun2023anticrispracriic5is pages 1-2): Wei Sun, Xiaolong Zhao, Jinlong Wang, Xiaoqi Yang, Zhi Cheng, Shuo Liu, Jiuyu Wang, Gang Sheng, and Yanli Wang. Anti-crispr acriic5 is a dsdna mimic that inhibits type ii-c cas9 effectors by blocking pam recognition. Nucleic Acids Research, 51:1984-1995, Feb 2023. URL: https://doi.org/10.1093/nar/gkad052, doi:10.1093/nar/gkad052. This article has 22 citations and is from a highest quality peer-reviewed journal.

10. (allemailem2024currentupdatesof pages 12-14): Khaled Allemailem, Ahmad Almatroudi, Faris Alrumaihi, Arwa Alradhi, Abdulrahman Theyab, Mohammad Algahtani, Mohmmed Alhawas, Gasim Dobie, Amira Moawad, Arshad Rahmani, and Amjad Khan. Current updates of crispr/cas system and anti-crispr proteins: innovative applications to improve the genome editing strategies. International Journal of Nanomedicine, 19:10185-10212, Oct 2024. URL: https://doi.org/10.2147/ijn.s479068, doi:10.2147/ijn.s479068. This article has 32 citations and is from a peer-reviewed journal.

11. (allemailem2024currentupdatesof pages 14-16): Khaled Allemailem, Ahmad Almatroudi, Faris Alrumaihi, Arwa Alradhi, Abdulrahman Theyab, Mohammad Algahtani, Mohmmed Alhawas, Gasim Dobie, Amira Moawad, Arshad Rahmani, and Amjad Khan. Current updates of crispr/cas system and anti-crispr proteins: innovative applications to improve the genome editing strategies. International Journal of Nanomedicine, 19:10185-10212, Oct 2024. URL: https://doi.org/10.2147/ijn.s479068, doi:10.2147/ijn.s479068. This article has 32 citations and is from a peer-reviewed journal.

12. (chen2024globalmarinemicrobial pages 1-2): Jianwei Chen, Yangyang Jia, Ying Sun, Kun Liu, Changhao Zhou, Chuan Liu, Denghui Li, Guilin Liu, Chengsong Zhang, Tao Yang, Lei Huang, Yunyun Zhuang, Dazhi Wang, Dayou Xu, Qiaoling Zhong, Yang Guo, Anduo Li, Inge Seim, Ling Jiang, Lushan Wang, Simon Ming Yuen Lee, Yujing Liu, Dantong Wang, Guoqiang Zhang, Shanshan Liu, Xiaofeng Wei, Zhen Yue, Shanmin Zheng, Xuechun Shen, Sen Wang, Chen Qi, Jing Chen, Chen Ye, Fang Zhao, Jun Wang, Jie Fan, Baitao Li, Jiahui Sun, Xiaodong Jia, Zhangyong Xia, He Zhang, Junnian Liu, Yue Zheng, Xin Liu, Jian Wang, Huanming Yang, Karsten Kristiansen, Xun Xu, Thomas Mock, Shengying Li, Wenwei Zhang, and Guangyi Fan. Global marine microbial diversity and its potential in bioprospecting. Nature, 633:371-379, Sep 2024. URL: https://doi.org/10.1038/s41586-024-07891-2, doi:10.1038/s41586-024-07891-2. This article has 182 citations and is from a highest quality peer-reviewed journal.

13. (xiao2024ecologicaldriversof pages 1-2): Wei Xiao, J. L. Weissman, and Philip L. F. Johnson. Ecological drivers of crispr immune systems. mSystems, Dec 2024. URL: https://doi.org/10.1128/msystems.00568-24, doi:10.1128/msystems.00568-24. This article has 6 citations and is from a peer-reviewed journal.

14. (elliott2024conditionsforthe pages 1-2): Josie F K Elliott, David V McLeod, Tiffany B Taylor, Edze R Westra, Sylvain Gandon, and Bridget N J Watson. Conditions for the spread of crispr-cas immune systems into bacterial populations. The ISME Journal, Jan 2024. URL: https://doi.org/10.1093/ismejo/wrae108, doi:10.1093/ismejo/wrae108. This article has 11 citations.

15. (sandsdalen2024exploringthefrozen pages 4-6): Greta Daae Sandsdalen, Animesh Kumar, and Erik Hjerde. Exploring the frozen armory: antiphage defense systems in cold-adapted bacteria with a focus on crispr-cas systems. Microorganisms, 12:1028, May 2024. URL: https://doi.org/10.3390/microorganisms12051028, doi:10.3390/microorganisms12051028. This article has 0 citations.

16. (allemailem2024currentupdatesof pages 10-12): Khaled Allemailem, Ahmad Almatroudi, Faris Alrumaihi, Arwa Alradhi, Abdulrahman Theyab, Mohammad Algahtani, Mohmmed Alhawas, Gasim Dobie, Amira Moawad, Arshad Rahmani, and Amjad Khan. Current updates of crispr/cas system and anti-crispr proteins: innovative applications to improve the genome editing strategies. International Journal of Nanomedicine, 19:10185-10212, Oct 2024. URL: https://doi.org/10.2147/ijn.s479068, doi:10.2147/ijn.s479068. This article has 32 citations and is from a peer-reviewed journal.

17. (allemailem2024currentupdatesof pages 24-25): Khaled Allemailem, Ahmad Almatroudi, Faris Alrumaihi, Arwa Alradhi, Abdulrahman Theyab, Mohammad Algahtani, Mohmmed Alhawas, Gasim Dobie, Amira Moawad, Arshad Rahmani, and Amjad Khan. Current updates of crispr/cas system and anti-crispr proteins: innovative applications to improve the genome editing strategies. International Journal of Nanomedicine, 19:10185-10212, Oct 2024. URL: https://doi.org/10.2147/ijn.s479068, doi:10.2147/ijn.s479068. This article has 32 citations and is from a peer-reviewed journal.

18. (allemailem2024currentupdatesof pages 16-18): Khaled Allemailem, Ahmad Almatroudi, Faris Alrumaihi, Arwa Alradhi, Abdulrahman Theyab, Mohammad Algahtani, Mohmmed Alhawas, Gasim Dobie, Amira Moawad, Arshad Rahmani, and Amjad Khan. Current updates of crispr/cas system and anti-crispr proteins: innovative applications to improve the genome editing strategies. International Journal of Nanomedicine, 19:10185-10212, Oct 2024. URL: https://doi.org/10.2147/ijn.s479068, doi:10.2147/ijn.s479068. This article has 32 citations and is from a peer-reviewed journal.

19. (kenny2024molecularmechanismsof pages 22-25): Molecular Mechanisms of Cyclic Oligoadenylate Signaling During Type III CRISPR-Cas Interference This article has 0 citations.

20. (rentz2024genomicmobilitytransposons pages 6-8): Luise Rentz, Finn O. Gehlert, and Ruth A. Schmitz. Genomic mobility: transposons in methanoarchaea. Methanogens - Unique Prokaryotes [Working Title], Nov 2024. URL: https://doi.org/10.5772/intechopen.1007828, doi:10.5772/intechopen.1007828. This article has 1 citations.

21. (sandsdalen2024exploringthefrozen pages 1-2): Greta Daae Sandsdalen, Animesh Kumar, and Erik Hjerde. Exploring the frozen armory: antiphage defense systems in cold-adapted bacteria with a focus on crispr-cas systems. Microorganisms, 12:1028, May 2024. URL: https://doi.org/10.3390/microorganisms12051028, doi:10.3390/microorganisms12051028. This article has 0 citations.